{"name":"Promontory Therapeutics Inc.","slug":"promontory-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AJBVV95cUxPcG02MzkwN3FNRFZGZnFTVEZWUXpIaUtiYVBNMlFkVEVOLS1OTVhhcWVUM284VkR1T0FNQkNWM2hxWE9HUXlmX1ZUTTBsRWZpOFlGVVExT19vMy0tX2hPRXRaX3FoMEQ5MFR5MEx2TVBIYV9DeUw1Q21FVzBYcWpNdXFMRkZtTWxuNjl3ZlE4VEZhYklIV295alFMeml3RzF4WlEzX0RkdHNTdkV3eG9sUGFUYjVtenlIR1VnV1RCQ293blNONVhnUGRBY3c4bFpsdW5WZzFWeEdoM0QxN2gwZmxnTmRkanBmU2VZNE43cVRveDlWVW5hekNnV3NvZWpjbnlxYjFYRVh4dkpWLVFHeU9sNEZkdVJ5eUZWRWF6TFhqV3N4a054V3VnZEY1aGx2UmFwVEpkZEZoVy1QNklnWVo2X2hCc2lydjhYVHotS0VyT3I0ZVgwcnRkaUg0dGxZ?oc=5","date":"2026-01-05","type":"regulatory","source":"PR Newswire UK","summary":"Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval and Wider Commercialization Opportunity in nmCSPC Segment | DelveInsight - PR New","headline":"Castration-sensitive Prostate Cancer Market Projected to Grow at a 13.2% CAGR (2020-2034), Driven by Expanded Approval a","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPOS12dlFjcFduMHVmQ2ZpMFk2SHZGU0ZYTENKVHlkdk5CY2hQUHpTM3hTRUdCdUtNMmgwZUxtNG5iMXVEMnhpeXZVZm1rZTFoa19lUzlveWlSbUJtNGFKck9BRTlOTXVmZ0RzZEFCR3hBbXpPdUtpUExGZnMyZUxBZ2R4ODJzVTZ5YlRkaUdyaGtfNGFKU3dHTHRrUVdhWktMU0NRc3JoM0xFY1F6eHAwREd0eEI5dFRVT2loemx2TjUzVE0?oc=5","date":"2025-12-24","type":"trial","source":"BioPharma APAC","summary":"Promontory Therapeutics Exceeds Interim Efficacy Bar In Thymoma Study With PT 112 - BioPharma APAC","headline":"Promontory Therapeutics Exceeds Interim Efficacy Bar In Thymoma Study With PT 112","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxOdUlBNTd2emRxTjRXaWQxN3R6eVVVTjdXUGhOdTd4S0tKWEJYODIzMlRYZ2tHZHVkZGpLbHR1bS1XQ05KRVQ1RUdpang3LWR3NUVqaU1hbndONENvNzBkSl93UlR4cjhEaURUd1JpOFlFYTVPY1BqeEVob056Q2s3NE0yajB5WjVTRk9PZnVQUzB2SWQtcGI3dXk1Q0tWRWlkM2daSExMajBhYldqVU5ES1hPbTJGUFhUcXZrOW1ZbW96V3BWY1IydG1KQVVyaTRVRXVyaDUxWGtxQ1EwcGJCdFpuQTk3bVRfMF9LTTBFLVhUYXJOblJ1bm5zMDk1MzItb01Vck9vV285ZC1GRDd0Mmo1aE1PcGdLNDZYWG1NOTBpWXBoRVFj?oc=5","date":"2025-12-22","type":"trial","source":"prnewswire.com","summary":"Promontory Therapeutics Announces Interim Efficacy Requirement Reached on Phase 2 Study of PT-112 Monotherapy in Patients with Recurrent Thymoma - prnewswire.com","headline":"Promontory Therapeutics Announces Interim Efficacy Requirement Reached on Phase 2 Study of PT-112 Monotherapy in Patient","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNMkE2c29YZWQxblJrYUgwUjhzNUhYNkxNdS1jdmNHMDd5cEhyVDVWSXJLTG1wN1pMVDBZYUtXTjJxb21lUXZFbVlkSEFOS3FDWDFGR2dxTjBJVW5qeWs2WTk2RkF0X2NoWEpmWUZwaUxuTm5vTXdVcHRpV1RCNUZoT1d5NjJUcGQtanJrbzJGLWlvUC1mRk9iYkxFcXJvRzB3Nm42SWtiQ0dmc3c?oc=5","date":"2025-05-20","type":"regulatory","source":"Targeted Oncology","summary":"FDA Oks Phase 3 Trial of PT-112 in mCRPC Following Successful EOP2 Meeting - Targeted Oncology","headline":"FDA Oks Phase 3 Trial of PT-112 in mCRPC Following Successful EOP2 Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AJBVV95cUxOeGFaWG4tX2xpZUphclpsVFpRQmg1Ym9UUVNaR3RGZXhkcVg5Q3VORTRPQW5zX3hOVlVocGJkMGZmLU9aRWxHMHBxUFh2bnN1aWxLR1d4Q3NYYVJyc2lkTk04cDAxYmtheUxWSVlVcWw0TXR0Q3BjTWdqYVB0TFlOU1dCMTRNUXJlYXVva1M3TzA2NG85d2RZWDhVclBiaGR5bVBDWnpjcjlsYlk5VW5JcFFrMWJTTF9WVml6eVNocXB4RHNDZVp5b1pEY3FRR2liSW04M2MxdE03d2pyMXB3Z3lSNHk4YjJVUFI1LU4xWmtLVFFENDVPT1pSQnFjMHJGWlR5bzhFZTVUMTMxRWVtb2c0SUFGNUd4dy15bEMxQ2JvT1ZiNVJsUFlsWEd2WEM1OGgtZE1NOUgwTUlOWVZJbWJvTHZIaHRpMkNnNHE2ZmswdWI2eDJkdk5hRmRGQ0IzU2loMmVPTERwVVlI?oc=5","date":"2025-02-17","type":"pipeline","source":"GlobeNewswire","summary":"Metastatic Castration-Resistant Prostate Cancer Market to - GlobeNewswire","headline":"Metastatic Castration-Resistant Prostate Cancer Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOTlItdElSeV9EVzhheGZxRzAyblVrWXRRUDB1NEV1T1JXYXgwM1YyUk1qUjR0QUl6MEhwNXB5d1VuZWlSbFZvYVRZYUhPWTJGd19rS0s5UVE4TkNnR1hYekM0Z1RJM1dZVHltVnJxaHFkUU1MVl85UUY2V2tOdmdJbndYcUVCRnozT2JkQThQR1lvRmRHMmdwVF9FNWhtTHZmTmdGUjFOSlBvMEk1dXV5SzBwamhIdjFNenhROWUySmV1SlA5dGgwOE53V0lZd0J6SFdrVDB0Qk40YnVWWklQUnpIalNuLVFoRlZ2QkJ2elZHM1diUWxjWGVOaERMRjZWVklZc01uVFhLMm5jWjdZdk5pX0pCbHc?oc=5","date":"2025-02-17","type":"pipeline","source":"GlobeNewswire","summary":"Cancer Vaccines Market on Track for Major Expansion in the - GlobeNewswire","headline":"Cancer Vaccines Market on Track for Major Expansion in the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"prnewswire.com","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - prnewswire.com","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOVVhFWm1VM2hWcmdCb1hqYlI4bEZBbzZPcVVDeHFaeHFkQmxjd0pNaU41dkxXRjl1Y0dhVFNhdVZicFp3THE0YktmX2RMaHBFUFlnRHlXd0tVVDVxalhvdWFhcktDa0lFM2lTRFdxdGJhSzY0SExwRnlyaFVLa0QyTlpMNTJ6WlpLcGhKQjln?oc=5","date":"2024-02-01","type":"pipeline","source":"Life Science Leader","summary":"Companies to Watch: Promontory Therapeutics - Life Science Leader","headline":"Companies to Watch: Promontory Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNDFrckE1VmpkY014T2VRaWp2WDl5bFdsMGVBa09SblA5LWFhbkJZakNVZTgwT29ucGtFQnhKeTR2QWlKbDBPYXNlaHlGSU5KVElzdm1jdk9kR203QV91ZnFLd1luMUtYUXBvMkdIVEJNMHhGZFFQZlpWUzZrUG4yNm84eFRSbXQ4UThNZUJOYndnbFQweGYxdE5zOFA1UFYzSnJFTERmSXhBOFhBVzFBODN0aDhVRnp3bEhITkdB?oc=5","date":"2022-05-20","type":"regulatory","source":"Fierce Biotech","summary":"Chutes & Ladders—Aquestive CEO heads for the exits while seizure med remains in regulatory limbo - Fierce Biotech","headline":"Chutes & Ladders—Aquestive CEO heads for the exits while seizure med remains in regulatory limbo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPQjFBOE1MTFg3X1lyVFhNS2xhOFI5UXlhbFJOcEUyYVR0VkNiZkVhQTQ5dWNlYXBRYnlSQ2NjYW9DY2d1ZE5hc19JbWpPMVhibFlIRElaUkZKRHZhbU0zZldJTTNET0U4dms3Yjl0TWdTWjE0Rk9OSVhtSGd3ZHZFcHNXQXhUanhsUkR1REppdjBodllvdWlPdktmLWJ0WGNRLXhRY1RiTkRDQms5SjRaQWRpYXNvTFJQOHBPc2VnTENwS0VFbm51dmNXS1Q5ZmVaalE?oc=5","date":"2022-05-05","type":"pipeline","source":"prnewswire.com","summary":"Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc. - prnewswire.com","headline":"Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc.","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}